Skip to content
GenoLensGenoLens

XDH

Chr 2p23.1

xanthine dehydrogenase

Aliases:
XOR, XO, XDH/XO
MANE:
ENST00000379416.4

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Nephrocalcinosis or nephrolithiasis

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

Disease associations (Open Targets)

  • xanthinuria type I

    0.74
  • gout

    0.70
  • leukemia

    0.60
  • hyperuricemia

    0.60
  • lymphoma

    0.60
  • xanthinuria type II

    0.56
  • cancer

    0.41
  • Myalgia

    0.37
  • eye inflammation

    0.37
  • Arthralgia

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Xanthine dehydrogenase/oxidase

Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro)

Curated MONDO disease pages that list XDH among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.